1.
Gynecol Oncol
; 52(3): 402-7, 1994 Mar.
Article
in English
| MEDLINE
| ID: mdl-8157199
ABSTRACT
We report the first case of primary fallopian tube adenocarcinoma in situ in a patient who had received antiestrogen tamoxifen as adjuvant therapy for breast carcinoma. Clinical and in vivo animal model studies, referable to the possible estrogen agonist effect of tamoxifen on the female genital tract, are also reviewed.
Subject(s)
Adenocarcinoma/chemically induced , Breast Neoplasms/drug therapy , Carcinoma in Situ/chemically induced , Fallopian Tube Neoplasms/chemically induced , Neoplasms, Second Primary/chemically induced , Tamoxifen/therapeutic use , Adenocarcinoma/pathology , Carcinoma in Situ/pathology , Chemotherapy, Adjuvant , Fallopian Tube Neoplasms/pathology , Female , Humans , Middle Aged , Tamoxifen/adverse effects
2.
S Afr Med J
; 81(10): 530-1, 1992 May 16.
Article
in English
| MEDLINE
| ID: mdl-1585229
